title: PSA spike after brachytherapy For localized prostate cancer.
abstract: A common concern for patients who have undergone treatment for prostate cancer and their families is an elevation or spike in the PSA level following definitive treatment. A number of factors can be responsible for this, but often the PSA spike may be benign. An informed health care worker can reasonably assess whether this is the case, and can help to alleviate the fears of the patient and his family.
authors.affiliation: Schiffler Cancer Center, Wheeling, WV, USA.
authors.forename: Laurie
authors.initials: L
authors.lastname: Abel
authors.forename: Debra
authors.initials: D
authors.lastname: Zeroski
authors.forename: Sarah
authors.initials: S
authors.lastname: Brammer
authors.forename: Wayne
authors.initials: W
authors.lastname: Butler
authors.forename: Kent E
authors.initials: KE
authors.lastname: Wallner
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Merrick
mesh_terms: D001918:Brachytherapy / Q000009:adverse effects* / Q000451:nursing; D006801:Humans; D008297:Male; D009730:Nursing Assessment; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000451:nursing / Q000532:radiotherapy*
chemical_list: D017430:Prostate-Specific Antigen